Amanda Farley1, Constantinos Koshiaris2, Jason Oke3, Ronan Ryan1, Lisa Szatkowski4, Richard Stevens2, Paul Aveyard2. 1. Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, United Kingdom. 2. Nuffield Department of Primary Care Health Sciences, UK Centre for Tobacco and Alcohol Studies, University of Oxford, Oxford, United Kingdom. 3. Nuffield Department of Primary Care Health Sciences, UK Centre for Tobacco and Alcohol Studies, University of Oxford, Oxford, United Kingdom jason.oke@phc.ox.ac.uk. 4. Division of Epidemiology and Public Health, UK Centre for Tobacco and Alcohol Studies, University of Nottingham, Nottingham, United Kingdom.
Abstract
PURPOSE: Smoking cessation after a diagnosis of lung, bladder, and upper aerodigestive tract cancer appears to improve survival, and support to quit would improve cessation. The aims of this study were to assess how often general practitioners provide active smoking cessation support for these patients and whether physician behavior is influenced by incentive payments. METHODS: Using electronic primary care records from the UK Clinical Practice Research Datalink, 12,393 patients with incident cases of cancer diagnosed between 1999 and 2013 were matched 1 to 1 to patients with incident cases of coronary heart disease (CHD) diagnosed during the same time. We assessed differences in the proportion for whom physicians updated smoking status, advised quitting, and prescribed cessation medications, as well as the proportion of patients who stopped smoking within a year of diagnosis. We further examined whether any differences arose because the physicians were offered incentives to address smoking in patients with CHD and not cancer. RESULTS: At diagnosis, 32.0% of patients with cancer and 18.2% of patients with CHD smoked tobacco. Patients with cancer were less likely than patients with CHD to have their general practitioners update smoking status (OR = 0.18; 95% CI, 0.17-0.19), advise quitting (OR = 0.38; 95% CI, 0.36-0.40), or prescribe medication (OR = 0.67; 95% CI, 0.63-0.73), and they were less likely to have stopped smoking (OR = 0.76; 95% CI, 0.69-0.84). One year later 61.7% of patients with cancer and 55.4% with CHD who were smoking at diagnosis were still smoking. Introducing incentive payments was associated with more frequent interventions, but not for patients with CHD specifically. CONCLUSIONS: General practitioners were less likely to support smoking cessation in patients with cancer than with CHD, and patients with cancer were less likely to stop smoking. This finding is not due to the difference in incentive payments.
PURPOSE: Smoking cessation after a diagnosis of lung, bladder, and upper aerodigestive tract cancer appears to improve survival, and support to quit would improve cessation. The aims of this study were to assess how often general practitioners provide active smoking cessation support for these patients and whether physician behavior is influenced by incentive payments. METHODS: Using electronic primary care records from the UK Clinical Practice Research Datalink, 12,393 patients with incident cases of cancer diagnosed between 1999 and 2013 were matched 1 to 1 to patients with incident cases of coronary heart disease (CHD) diagnosed during the same time. We assessed differences in the proportion for whom physicians updated smoking status, advised quitting, and prescribed cessation medications, as well as the proportion of patients who stopped smoking within a year of diagnosis. We further examined whether any differences arose because the physicians were offered incentives to address smoking in patients with CHD and not cancer. RESULTS: At diagnosis, 32.0% of patients with cancer and 18.2% of patients with CHD smoked tobacco. Patients with cancer were less likely than patients with CHD to have their general practitioners update smoking status (OR = 0.18; 95% CI, 0.17-0.19), advise quitting (OR = 0.38; 95% CI, 0.36-0.40), or prescribe medication (OR = 0.67; 95% CI, 0.63-0.73), and they were less likely to have stopped smoking (OR = 0.76; 95% CI, 0.69-0.84). One year later 61.7% of patients with cancer and 55.4% with CHD who were smoking at diagnosis were still smoking. Introducing incentive payments was associated with more frequent interventions, but not for patients with CHD specifically. CONCLUSIONS: General practitioners were less likely to support smoking cessation in patients with cancer than with CHD, and patients with cancer were less likely to stop smoking. This finding is not due to the difference in incentive payments.
Authors: Lisa Sanderson Cox; Jeff A Sloan; Christi A Patten; James A Bonner; Susan M Geyer; William L McGinnis; Phillip J Stella; Randolph S Marks Journal: Psychooncology Date: 2002 Nov-Dec Impact factor: 3.894
Authors: Mark S Walker; Damon J Vidrine; Ellen R Gritz; Randy J Larsen; Yan Yan; Ramaswamy Govindan; Edwin B Fisher Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-11-28 Impact factor: 4.254
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Benjamin Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; Carolyn Dresler Journal: J Thorac Oncol Date: 2013-05 Impact factor: 15.609
Authors: Mary E Cooley; Linda Sarna; Jenny Kotlerman; Jeanne M Lukanich; Michael Jaklitsch; Sarah B Green; Raphael Bueno Journal: Lung Cancer Date: 2009-03-24 Impact factor: 5.705
Authors: Graham W Warren; James R Marshall; K Michael Cummings; Benjamin A Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; James L Mulshine; Nasser Hanna; Carolyn A Dresler Journal: J Oncol Pract Date: 2013-07-29 Impact factor: 3.840
Authors: Titus Josef Brinker; Christian Martin Brieske; Stefan Esser; Joachim Klode; Ute Mons; Anil Batra; Tobias Rüther; Werner Seeger; Alexander H Enk; Christof von Kalle; Carola Berking; Markus V Heppt; Martina V Gatzka; Breno Bernardes-Souza; Richard F Schlenk; Dirk Schadendorf Journal: J Med Internet Res Date: 2018-08-15 Impact factor: 5.428
Authors: Meredith Elana Giuliani; Geoffrey Liu; Wei Xu; Mihaela Dirlea; Peter Selby; Janet Papadakos; Nazek Abdelmutti; Dongyang Yang; Lawson Eng; David Paul Goldstein; Jennifer Michelle Jones Journal: J Med Internet Res Date: 2019-04-09 Impact factor: 5.428
Authors: Charlotte Albury; Rebecca Barnes; Anne Ferrey; Tim Coleman; Hazel Gilbert; Felix Naughton; Paul Aveyard; Rachna Begh Journal: Addiction Date: 2021-12-23 Impact factor: 7.256